Pheochromocytoma Diagnosed during the Treatment of Diffuse Alveolar Hemorrhage, a Diagnostic Necessity before Using High-dose Glucocorticoids

Intern Med. 2021 Sep 1;60(17):2825-2830. doi: 10.2169/internalmedicine.6827-20. Epub 2021 Mar 15.

Abstract

A 46-year-old woman with exacerbating hemoptysis and dyspnea was diagnosed with diffuse alveolar hemorrhage (DAH). High doses of glucocorticoids were initiated, but afterward, paroxysmal hypertension (210/140 mmHg) with headache and abdominal pain appeared. A 50-mm left adrenal tumor with an intense uptake by iodine-123 metaiodobenzylguanidine scintigraphy and catecholamine hypersecretion revealed complication with pheochromocytoma. Because high doses of glucocorticoids, sometimes required for DAH, can provoke life-threatening paroxysmal hypertension in pheochromocytoma and paraganglioma (PPGL), our case suggests that PPGL needs to be recognized as the cause of DAH and should be detected with whole-body imaging before starting glucocorticoids.

Keywords: catecholamine crisis; diffuse alveolar hemorrhage; high-dose glucocorticoids; pheochromocytoma.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / diagnostic imaging
  • Female
  • Glucocorticoids / therapeutic use
  • Hemorrhage / chemically induced
  • Humans
  • Middle Aged
  • Paraganglioma* / diagnostic imaging
  • Paraganglioma* / drug therapy
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / diagnostic imaging

Substances

  • Glucocorticoids